| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,502,723 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$6,502,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -131.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice PresidentOfficer |
• – – |
2011-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,073 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice PresidentOfficer |
• – – |
2012-01-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,073 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-07-01 |
4 |
A |
$30.20 |
$2,295 |
D/D |
76 |
1,892 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-01-02 |
4 |
AS |
$62.75 |
$4,769 |
D/D |
(76) |
1,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-01-01 |
4 |
A |
$24.20 |
$1,912 |
D/D |
79 |
848 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-07-31 |
4 |
AS |
$31.50 |
$2,489 |
D/D |
(79) |
1,813 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-07-01 |
4 |
A |
$48.59 |
$6,170 |
D/D |
127 |
4,553 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-04 |
4 |
AS |
$61.00 |
$7,747 |
D/D |
(127) |
4,358 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-01 |
4 |
A |
$47.71 |
$6,202 |
D/D |
130 |
4,485 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-12-20 |
4 |
AS |
$52.48 |
$6,822 |
D/D |
(130) |
7,872 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2018-01-01 |
4 |
A |
$42.76 |
$6,670 |
D/D |
156 |
11,782 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-07-24 |
4 |
AS |
$47.03 |
$7,337 |
D/D |
(156) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
CEO Level 15 |
• • – |
2023-08-31 |
4 |
A |
$30.56 |
$4,798 |
D/D |
157 |
121,881 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-07-01 |
4 |
A |
$40.66 |
$6,627 |
D/D |
163 |
11,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2018-01-02 |
4 |
AS |
$50.00 |
$8,150 |
D/D |
(163) |
11,619 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• • – |
2019-07-01 |
4 |
A |
$45.70 |
$7,907 |
D/D |
173 |
22,444 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-02 |
4 |
AS |
$60.25 |
$10,423 |
D/D |
(173) |
16,285 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-01-01 |
4 |
A |
$30.05 |
$5,949 |
D/D |
198 |
2,011 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-07-02 |
4 |
AS |
$56.30 |
$11,147 |
D/D |
(198) |
4,355 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-01 |
4 |
A |
$36.45 |
$7,654 |
D/D |
210 |
16,051 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• • – |
2019-07-02 |
4 |
AS |
$66.40 |
$13,944 |
D/D |
(210) |
22,234 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-07-01 |
4 |
A |
$35.42 |
$7,580 |
D/D |
214 |
15,997 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-02 |
4 |
AS |
$53.50 |
$11,449 |
D/D |
(214) |
15,837 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
VP, Antisense Drug Discovery |
• – – |
2013-01-01 |
4 |
A |
$8.87 |
$1,908 |
D/D |
215 |
5,599 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-07-02 |
4 |
AS |
$28.69 |
$6,169 |
D/D |
(215) |
5,842 |
0 |
- |
|
116 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
